P437 Risk of immunomediated adverse events or secondary...

Journal of Crohn's and Colitis 2019 / 01 Vol. 13; Iss. Supplement

P437 Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry

Calafat, M, Mañosa, M, Panes, J, Nos, P, Iglesias, E, Vera, I, López-Sanromán, A, Guardiola, J, Taxonera, C, Mínguez, M, Martín, M D, de Castro, L, Riestra, S, Rivero, M, García-Planella, E, Calvet, X
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.561
Date:
January, 2019
File:
PDF, 141 KB
2019
Conversion to is in progress
Conversion to is failed